Untargeted metabolomics in the fight for patient diagnosis
14 Nov 2023
In this video from Thermo Fisher Scientific, join Anne M. Evans, Senior Director and Head of Core Research at Metabolon as she discusses how metabolomics is the nexus of gene-environment interactions with broad utility in understanding health and disease, and how it can be implemented into patient diagnosis.
About the company
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
